|Journal||Frontiers in Pharmacology|
|State||Published - Sep 7 2021|
Bibliographical noteFunding Information:
This work was supported by the National Institutes of Health 1R01DK121797-01A1 (TH) and 1R01DK126884-01A1 (DS), the National Heart, Lung and Blood Institute K01HL-125445 (TH) and P01 HL05197-11 (DS), and the National Institute of General Medical Sciences P20GM104357-02 (DS) and NIDDK R01 DK104714 (BW) and R01 DK125846 (BW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
- insulin resistance
- reactive oxygen species
ASJC Scopus subject areas
- Pharmacology (medical)